Gill v. Burress

382 S.W.3d 57, 92 A.L.R. 6th 713, 2012 WL 1231967, 2012 Ky. App. LEXIS 63
CourtCourt of Appeals of Kentucky
DecidedApril 13, 2012
DocketNo. 2011-CA-000332-MR
StatusPublished
Cited by7 cases

This text of 382 S.W.3d 57 (Gill v. Burress) is published on Counsel Stack Legal Research, covering Court of Appeals of Kentucky primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Gill v. Burress, 382 S.W.3d 57, 92 A.L.R. 6th 713, 2012 WL 1231967, 2012 Ky. App. LEXIS 63 (Ky. Ct. App. 2012).

Opinion

OPINION

MOORE, Judge:

Paula K. Gill, D.M.D., appeals a summary judgment entered by the Fayette Circuit Court in favor of Susan M. Bur-ress, M.D., after the circuit court determined that Burress conclusively proved that Gill would be unable to establish damages arising out of Burress’s alleged professional negligence in failing to detect a mass in Gill’s breast consistent with ductal carcinoma for a period of approximately eighteen months. We find that issues of material fact exist relating to certain elements of damage properly recoverable by Gill, but that other damages claimed by Gill are not recoverable in this case as a matter of law. Therefore, we affirm in part, reverse in part, and remand for further proceedings.

I. FACTUAL AND PROCEDURAL HISTORY

Burress is a doctor of obstetrics and gynecology (also known as an “Ob/GYN”), and Gill was under Burress’s care and treatment from 1994 through 2005. Relevant to this case are Gill’s visits to Bur-ress’s office on November 7, 2008 (when Gill was 41 years of age), and December 3, 2004 (when Gill was 42). During both visits, Burress physically examined Gill’s breasts for palpable lesions and found nothing indicative of cancer. However, no record relating to Burress’s treatment of Gill indicates that Burress ever recommended Gill follow up with a mammogram. Gill also testified, via deposition, that Bur-ress advised her following both of these physical examinations that it would be unnecessary for her to obtain an additional examination by means of a mammogram.1

Gill further testified that she relied upon Burress’s advice until early or mid-May, 2005, at which point she discovered, through self-examination, a lump about 1.7 centimeters in diameter in the upper part of her left breast. Approximately one month later, Gill obtained a mammogram of the area in question, which ultimately led to a diagnosis of stage II or IIA cancer in June, 2005. Thereafter, Gill underwent treatment that included radiation, a lumpectomy, chemotherapy, and the removal of her ovaries.2

On June 5, 2006, Gill filed her complaint against Burress in this matter. Gill’s complaint alleged that Burress had acted neg[60]*60ligently in failing to recommend that Gill follow up her November 7, 2003 and December 3, 2004 physical examinations with mammograms and in dissuading Gill from doing so, and that on either occasion a mammogram of Gill’s breast probably would have revealed the cancer at issue. Gill asserted that the delay in diagnosis and treatment caused her to suffer an injury. She categorized her damages as future physical pain, mental anguish, emotional distress and loss of ability to enjoy life; past and future medical expenses; loss of her ability to earn money; and lost time from her work as a dentist.

Gill produced two expert witnesses who testified via deposition in support of her claim: a surgical oncologist, Dr. Harry Bear, and a radiologist, Dr. Avinash Sud. As to the applicable standard of care, Dr. Bear testified:

DR. BEAR: I think Ob[GYNs], following a patient, acting as one of their primary care providers, should be sure that the patient — all patients, all women should have annual screening mammograms after age 40. And for women with augmentation implants,[3] they should be getting diagnostic mammograms on an annual basis because they represent a special circumstance that can make diagnosis more difficult....
COUNSEL: And I believe — and, please, I’m not trying to put words in your mouth — that you said patients with breast augmentation should have diagnostic mammograms as opposed to screening mammograms, correct?
DR. BEAR: That’s my opinion, yes.
COUNSEL: And that goes to some of the special circumstances that apply to that situation?
DR. BEAR: Right. They’re more difficult and they need special views to see all the breast tissue.

As to the probability of a diagnostic mammogram detecting Gill’s cancer prior to June, 2005, Dr. Bear further testified:

DR. BEAR: I would say 80 percent likelihood it was detectable [in 2004]. Eighty to ninety percent likelihood it was detectable six months before it was found on physical exam or self exam and probably sixty percent — sixty to seventy percent likelihood that it was detectable by mammography in 2003.

Dr. Bear also opined regarding whether Gill’s regime of cancer treatment would have been less taxing if her cancer had been diagnosed prior to June, 2005:

DR. BEAR: So six months earlier, if she had not had positive nodes, she might have gotten either no chemotherapy or less aggressive or a less toxic course of chemotherapy. Certainly a year and a half earlier I think it’s much more likely she would have had negative nodes and smaller — and a tumor that was less than a centimeter. In which case she might have only had radiation and hormonal therapy and might not have had to have the extra surgery to clean up the margins which she had. But that’s as big a deal as having chemotherapy. I think the main difference is the chemotherapy.
COUNSEL: Okay. And then going back the year and a half or so?
DR. BEAR: Even more likely she could have avoided chemotherapy a year and a half earlier or two years earlier.

For his part, Dr. Sud testified that a mammogram probably would have detected Gill’s cancerous lesion in 2004. Dr. Sud added that “if it was diagnosed earlier, all I can say is that [Gill’s] survival would [61]*61have been more favorable and her treatment would have been less.”

Finally, Dr. Bear testified that as a direct result of the delay in Gill’s cancer diagnosis, it was likelier that Gill could have another bout with cancer:4

DR. BEAR: So we tend to look at the ten-year relapse-free survival rates for patients with breast cancer. Which really tells us who’s going to be cured and who’s not going to be cured. And I would say that the ten-year distant relapse survival rate for a patient with stage II breast cancer is probably more like 70 to 75 percent....
COUNSEL: And what is your understanding of Dr. Gill’s current condition? DR. BEAR: As far as I know from looking at her records, she’s free of disease. ...
[[Image here]]
COUNSEL: And if this had been, as you’ve suggested, diagnosed, say, six months earlier, how would in your opinion that have changed?
DR. BEAR: So six months earlier I think is a tough time to put much on. But if I say she had a 75 percent ten-year distant disease-free survival rate, which is just a rounded number, it probably would have been more like 80, 85 percent six months earlier. But certainly closer to that 90, 95 percent a year and a half earlier.
COUNSEL: Okay. And that would be the 2003?
DR. BEAR: 2003.

After discovery was completed, Burress moved for summary judgment, arguing that Gill had asserted a claim for damages which were not recoverable under Kentucky law. Burress based her motion largely upon Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

University of Kentucky v. Caitlin Huff
Court of Appeals of Kentucky, 2024
Legna Tocado Rodriguez v. Jeffrey B. Sharp
Court of Appeals of Kentucky, 2024
Smart & Associates, LLC v. Independent Liquor (NZ) Ltd.
226 F. Supp. 3d 828 (W.D. Kentucky, 2016)
Kiper v. Commonwealth
399 S.W.3d 736 (Kentucky Supreme Court, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
382 S.W.3d 57, 92 A.L.R. 6th 713, 2012 WL 1231967, 2012 Ky. App. LEXIS 63, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gill-v-burress-kyctapp-2012.